Literature DB >> 19107369

Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.

Shixin Bao1, Weimin Yang, Siwei Zhou, Zhangqun Ye.   

Abstract

The association between the single nucleotide polymorphisms (SNPs) in -174G/C and -634C/G of interleukin-6 (IL-6) promoter region and prostate cancer was examined in the population of Han people in Hubei region. TaqMan PCR was employed for the gene-typing of -174G/C and -634C/G in promoter region of IL-6 gene to compare the prostate cancer patients and normal controls in terms of genotype frequency, allele frequency and risk of prostate cancer. Enzyme-linked immunosorbent assay (ELISA) was used for the detection of IL-6 concentration in peripheral blood of the patients with prostate cancer and the relationship between the IL-6 level and the genotype was studied. Our results showed that in all the subjects, the genotype of genetic locus -174G/C was found to be GG and no CG and CC were observed. There was a significant difference in gene frequency of GG, CG and CC of -634C/G and allele frequency of G and C between prostate cancer patients and normal controls (P<0.05) and the gene frequency of GG+CG increased with the clinical stages and pathological grades of prostate cancer. The IL-6 level in GG+CG group was significantly higher than that in CC group. It was concluded that no SNP in -174G/C IL-6 promoter region was found in the population of Han people in Hubei region. The SNP in -634C/G was, to some extent, associated with the development and progression of prostate cancer. The population with GG+CG genetype has higher risk for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107369     DOI: 10.1007/s11596-008-0618-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  11 in total

1.  The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.

Authors:  Jianfeng Xu; James Lowey; Fredrik Wiklund; Jielin Sun; Fredrik Lindmark; Fang-Chi Hsu; Latchezar Dimitrov; Baoli Chang; Aubrey R Turner; Wennan Liu; Hans-Olov Adami; Edward Suh; Jason H Moore; S Lilly Zheng; William B Isaacs; Jeffrey M Trent; Henrik Grönberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

Review 2.  Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.

Authors:  Tomonori Habuchi
Journal:  Future Oncol       Date:  2006-04       Impact factor: 3.404

3.  The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population.

Authors:  R Zhai; G Liu; C Yang; C Huang; C Wu; D C Christiani
Journal:  Pharmacogenetics       Date:  2001-11

4.  Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6.

Authors:  E D Cox; S C Hoffmann; B S DiMercurio; R A Wesley; D M Harlan; A D Kirk; P J Blair
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

5.  1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.

Authors:  W Somers; M Stahl; J S Seehra
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

6.  Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.

Authors:  Dominique S Michaud; Sarah E Daugherty; Sonja I Berndt; Elizabeth A Platz; Meredith Yeager; E David Crawford; Ann Hsing; Wen-Yi Huang; Richard B Hayes
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

7.  Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes.

Authors:  A Kitamura; G Hasegawa; H Obayashi; K Kamiuchi; M Ishii; M Yano; T Tanaka; M Yamaguchi; H Shigeta; M Ogata; N Nakamura; T Yoshikawa
Journal:  Diabet Med       Date:  2002-12       Impact factor: 4.359

8.  The --174 G to C polymorphism of interleukin-6 gene is very rare in koreans.

Authors:  Chun Soo Lim; Shouhuan Zheng; Yon Su Kim; Curie Ahn; Jin Suk Han; Suhnggwon Kim; Jung Sang Lee; Dong-Wang Chae
Journal:  Cytokine       Date:  2002-07-07       Impact factor: 3.861

9.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

10.  Influence of cytokine gene polymorphisms on the development of prostate cancer.

Authors:  Sarah L McCarron; Stephen Edwards; Philip R Evans; Roz Gibbs; David P Dearnaley; Anna Dowe; Christine Southgate; Douglas F Easton; Rosalind A Eeles; W Martin Howell
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  15 in total

1.  Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer.

Authors:  Yan-Li Qu; Hong Yu; Yan-Zhi Chen; Yu-Xia Zhao; Guang-Jun Chen; Lu Bai; Dan Liu; Hong-Xin Su; He-Tong Wang
Journal:  Tumour Biol       Date:  2014-06-22

2.  Association of Variants in IL6-Related Genes with Lung Cancer Risk in Moroccan Population.

Authors:  Houda Kaanane; Nezha Senhaji; Hind Berradi; Nadia Benchakroun; Abdellatif Benider; Mehdi Karkouri; Hicham El Attar; Meriem Khyatti; Sellama Nadifi
Journal:  Lung       Date:  2019-08-29       Impact factor: 2.584

3.  Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer.

Authors:  Lu Bai; Hong Yu; Hetong Wang; Hongxin Su; Junhua Zhao; Yuxia Zhao
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

4.  Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.

Authors:  J F Magalhães; A J Cortinhas; C M Albuquerque; C S Baptista; R Ribeiro; Carlos Viegas; Augusto Matos; João Machado; Maria A Pires; Henrique Guedes-Pinto; A Martins-Bessa; J C Leitão; E Bastos
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

5.  Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.

Authors:  Mingyuan Yang; Chao Li; Ming Li
Journal:  Biomed Rep       Date:  2014-06-16

6.  Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.

Authors:  Geng Tian; Jia Mi; Xiaodan Wei; Dongmei Zhao; Lingyan Qiao; Chunhua Yang; Xianglin Li; Shuping Zhang; Xuri Li; Bin Wang
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

7.  Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.

Authors:  Kaiping Zhang; Li Zhang; Jun Zhou; Zongyao Hao; Song Fan; Cheng Yang; Chaozhao Liang
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

8.  Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.

Authors:  Tong-Zu Liu; Zhong-Qiang Guo; Ting Wang; Yue Cao; Di Huang; Xing-Huan Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Relevance of Interleukins 6 and 8 Single Nucleotide Polymorphisms in Prostate Cancer: A Multicenter Study.

Authors:  Amany A Ghazy; Mohammed Jayed Alenzi
Journal:  Prostate Cancer       Date:  2021-07-06

10.  Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population.

Authors:  Shengli Tang; Zhisu Liu; Yongxi Zhang; Yueming He; Dingyu Pan; Yuanyuan Liu; Quanyan Liu; Zhonglin Zhang; Yufeng Yuan
Journal:  Dis Markers       Date:  2013-11-25       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.